SEARCH:   Advanced

Blood, Vol. 112, Issue 8, 3500-3507, October 15, 2008 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia Blood Lee et al. 112: 3500 Supplemental materials for: Lee et al Files in this Data Supplement: Table S1. Characteristics of patients with chronic myeloid leukemia receiving Imatinib before transplantation, 1999–2004, reported to the CIBMTR (PDF, 14 KB) Table S2. Univariate analysis for overall survival and treatment-related mortality for patients in first chronic phase (PDF, 16.1 KB) Table S3. Characteristics of patients in first chronic phase who received IM prior to HCT, by reason for proceeding to HCT (PDF, 13.7 KB) This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020